Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor.

Prostaglandin D2 (PGD2) is released following exposure of asthmatics to allergen and acts via the adenylyl cyclase-coupled receptor for PGD2 (DP receptor). In this study, it is reported that human eosinophils possess this receptor, which would be expected to inhibit their activation. In contrast, it was found that prostaglandin D2 is a potent stimulator of eosinophil chemotaxis, actin polymerization, CD11b expression, and L-selectin shedding. These responses are specific for eosinophils, as neutrophils display little or no response to prostaglandin D2. They were not due to interaction with receptors for other prostanoids, as prostaglandins E2 and F(2alpha), U46619 (a thromboxane A2 analogue), and carbaprostacyclin (a prostacyclin analogue) displayed little or no activity. Furthermore, they were not shared by the selective DP receptor agonist BW245C and were not prevented by the selective DP receptor antagonist BWA868C, indicating that they were not mediated by DP receptors. In contrast, the prostaglandin D2 metabolite 13,14-dihydro-15-oxoprostaglandin D2 induced eosinophil activation but did not stimulate DP receptor-mediated adenosine 3',5'-cyclic monophosphate (cAMP) formation. These results indicate that in addition to the classic inhibitory DP1 receptor, eosinophils possess a second, novel DP2 receptor that is associated with PGD2-induced cell activation. These 2 receptors appear to interact to regulate eosinophil responses to PGD2, as blockade of DP1 receptor-mediated cAMP production by BWA868C resulted in enhanced DP2 receptor-mediated stimulation of CD11b expression. The balance between DP1 and DP2 receptors could determine the degree to which prostaglandin D2 can activate eosinophils and may play a role in eosinophil recruitment in asthma.

[1]  Lu Jin Prostaglandin D_2 and sleep regulation , 2002 .

[2]  J. Rokach,et al.  Eotaxin and RANTES enhance 5-oxo-6,8,11,14-eicosatetraenoic acid-induced eosinophil chemotaxis. , 2001, The Journal of allergy and clinical immunology.

[3]  K. Sugamura,et al.  Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor Crth2 , 2001, The Journal of experimental medicine.

[4]  J Bousquet,et al.  Asthma. From bronchoconstriction to airways inflammation and remodeling. , 2000, American journal of respiratory and critical care medicine.

[5]  K. Sugamura,et al.  Cutting Edge: Differential Production of Prostaglandin D2 by Human Helper T Cell Subsets , 2000, The Journal of Immunology.

[6]  P. Colville-Nash,et al.  Cyclopentenone prostaglandins—new allies in the war on inflammation , 2000, Nature Medicine.

[7]  松岡 俊行 Prostaglandin D2 as a mediator of allergic asthmaに関する研究 , 2000 .

[8]  K. Sugamura,et al.  CRTH2, an orphan receptor of T‐helper‐2‐cells, is expressed on basophils and eosinophils and responds to mast cell‐derived factor(s) , 1999, FEBS letters.

[9]  M. Lindsay,et al.  Pharmacology of the eosinophil. , 1999, Pharmacological reviews.

[10]  D. Gilroy,et al.  Inducible cyclooxygenase may have anti-inflammatory properties , 1999, Nature Medicine.

[11]  K. Sugamura,et al.  Selective expression of a novel surface molecule by human Th2 cells in vivo. , 1999, Journal of immunology.

[12]  L. Walch,et al.  Prostanoid receptors involved in the relaxation of human pulmonary vessels , 1999, British journal of pharmacology.

[13]  L. Walch,et al.  Prostanoid receptors involved in the relaxation of human bronchial preparations , 1999, British journal of pharmacology.

[14]  Y. Urade,et al.  Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Narumiya,et al.  Prostanoid receptors: structures, properties, and functions. , 1999, Physiological reviews.

[16]  Y. Urade,et al.  Prostaglandin D2 and sleep regulation. , 1999, Biochimica et biophysica acta.

[17]  W. Powell,et al.  5-oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of L-selectin shedding, surface expression of CD11b, actin polymerization, and calcium mobilization in human eosinophils. , 1999, American journal of respiratory cell and molecular biology.

[18]  J. Rokach,et al.  Biological inactivation of 5-oxo-6,8,11,14-eicosatetraenoic acid by human platelets. , 1999, Blood.

[19]  K. Chung,et al.  Inflammatory mediators of asthma: an update. , 1998, Pharmacological reviews.

[20]  A. Ford-hutchinson,et al.  Characterization of the recombinant human prostanoid DP receptor and identification of L‐644,698, a novel selective DP agonist , 1998, British journal of pharmacology.

[21]  J. Rokach,et al.  TOTAL SYNTHESIS OF A POTENT PROINFLAMMATORY 5-OXO-ETE AND ITS 6,7-DIHYDRO BIOTRANSFORMATION PRODUCT , 1998 .

[22]  桐山 通隆 Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells , 1998 .

[23]  J. Beleta,et al.  Inhibition of eotaxin‐mediated human eosinophil activation and migration by the selective cyclic nucleotide phosphodiesterase type 4 inhibitor rolipram , 1997, British journal of pharmacology.

[24]  A. Dubois,et al.  Inhibition of PAF-induced expression of CD11b and shedding of L-selectin on human neutrophils and eosinophils by the type IV selective PDE inhibitor, rolipram. , 1997, The European respiratory journal.

[25]  A. Hatzelmann,et al.  Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects , 1996, British journal of pharmacology.

[26]  G. Murphy,et al.  Metalloproteinase-mediated Regulation of L-selectin Levels on Leucocytes (*) , 1996, The Journal of Biological Chemistry.

[27]  L. Roberts,et al.  Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: an argument for a different DP receptor? , 1995, The Journal of pharmacology and experimental therapeutics.

[28]  J. Nadel,et al.  Elevated intracellular cyclic AMP inhibits chemotaxis in human eosinophils. , 1995, Cellular signalling.

[29]  W. Powell,et al.  5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration. , 1995, Journal of immunology.

[30]  W. Powell,et al.  Stimulation of human neutrophils by 5-oxo-6,8,11,14-eicosatetraenoic acid by a mechanism independent of the leukotriene B4 receptor. , 1993, The Journal of biological chemistry.

[31]  S. Georas,et al.  Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1 beta-induced transendothelial migration. , 1992, Journal of immunology.

[32]  E. Schulman,et al.  Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils. , 1992, Journal of immunology.

[33]  K. Blaser,et al.  An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. , 1991, Journal of immunological methods.

[34]  K. Rabe,et al.  Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan‐stimulated respiratory burst by ‘type IV’‐selective PDE inhibitors , 1991, British journal of pharmacology.

[35]  H. Kita,et al.  Regulation of Ig-induced eosinophil degranulation by adenosine 3',5'-cyclic monophosphate. , 1991, Journal of immunology.

[36]  K. Schrör,et al.  PGD2 and its mimetic ZK 110.841 are potent inhibitors of receptor-mediated activation of human neutrophils. , 1991, Eicosanoids.

[37]  Y. Urade,et al.  Mast cells contain spleen-type prostaglandin D synthetase. , 1990, The Journal of biological chemistry.

[38]  Butchers Pr,et al.  The effect of prostanoids on the function of human eosinophils. , 1990 .

[39]  P. Butchers,et al.  The effect of prostanoids on the function of human eosinophils. , 1990, Agents and actions. Supplements.

[40]  Y. Urade,et al.  The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. , 1989, Journal of immunology.

[41]  J. Nadel,et al.  Prostaglandin D2 causes accumulation of eosinophils in the lumen of the dog trachea. , 1989, Journal of applied physiology.

[42]  R. A. Coleman,et al.  Prostanoid‐induced contraction of human bronchial smooth muscle is mediated by TP‐receptors , 1989, British journal of pharmacology.

[43]  A. Robertson,et al.  The classification of prostaglandin DP‐receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist , 1989, British journal of pharmacology.

[44]  P. Norman,et al.  Characterisation of receptors mediating the contractile effects of prostanoids in guinea-pig and human airways. , 1988, European journal of pharmacology.

[45]  J. Murray,et al.  Release of prostaglandin D2 into human airways during acute antigen challenge. , 1986, The New England journal of medicine.

[46]  C. Oresajo,et al.  The kinetics of chemotactic peptide-induced change in F-actin content, F-actin distribution, and the shape of neutrophils , 1985, The Journal of cell biology.

[47]  S. Narumiya,et al.  Different responsiveness of prostaglandin D2‐sensitive systems to prostaglandin D2 and its analogues , 1985, British journal of pharmacology.

[48]  P. Rao,et al.  The effect of prostaglandin D2 (PGD2) on circulating eosinophils. , 1984, Prostaglandins, leukotrienes, and medicine.

[49]  J. Casals-stenzel,et al.  Pharmacological and cardiovascular properties of a hydantoin derivative, BW 245 C, with high affinity and selectivity for PGD2 receptors. , 1983, Prostaglandins.

[50]  J. Oates,et al.  Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. , 1982, Journal of immunology.

[51]  O. V. Miller,et al.  Evidence for distinct prostaglandin I2 and D2 receptors in human platelets. , 1979, The Journal of pharmacology and experimental therapeutics.

[52]  B. Samuelsson,et al.  Occurrence and properties of a prostaglandin F2alpha receptor in bovine corpora lutea. , 1975, European journal of biochemistry.

[53]  K. Morita,et al.  Catecholamine releasing factor in bovine adrenal medulla , 1975, FEBS letters.

[54]  A. Kay Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes. , 1970, Clinical and experimental immunology.

[55]  A. Böyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.